Raiffeisen Bank International AG Has $252,000 Stake in Cardinal Health, Inc. $CAH

Raiffeisen Bank International AG reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 71.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,633 shares of the company’s stock after selling 4,108 shares during the quarter. Raiffeisen Bank International AG’s holdings in Cardinal Health were worth $252,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Norges Bank acquired a new position in Cardinal Health during the second quarter valued at approximately $584,420,000. Acadian Asset Management LLC boosted its position in shares of Cardinal Health by 92.5% during the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after purchasing an additional 807,063 shares in the last quarter. Prudential Financial Inc. grew its holdings in shares of Cardinal Health by 476.8% in the 2nd quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock valued at $148,402,000 after buying an additional 730,209 shares during the period. Voya Investment Management LLC increased its position in shares of Cardinal Health by 298.3% in the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after buying an additional 615,398 shares in the last quarter. Finally, AustralianSuper Pty Ltd increased its position in shares of Cardinal Health by 237.6% in the 3rd quarter. AustralianSuper Pty Ltd now owns 680,173 shares of the company’s stock valued at $106,760,000 after buying an additional 478,689 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Performance

NYSE:CAH opened at $224.22 on Monday. The stock has a 50-day simple moving average of $211.38 and a 200 day simple moving average of $184.89. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $230.81. The company has a market cap of $52.76 billion, a PE ratio of 32.26, a PEG ratio of 1.45 and a beta of 0.64.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, February 5th. The company reported $2.63 EPS for the quarter, beating the consensus estimate of $2.31 by $0.32. The firm had revenue of $65.63 billion for the quarter, compared to analysts’ expectations of $64.88 billion. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The business’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.93 EPS. On average, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be given a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 29.35%.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $209.00 to $243.00 and gave the stock a “neutral” rating in a report on Tuesday, February 10th. Leerink Partners raised their price target on Cardinal Health from $240.00 to $268.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Mizuho lifted their price objective on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a report on Friday, February 6th. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Finally, Argus raised their target price on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $244.20.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.